| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Morrell Martha | CHIEF MEDICAL OFFICER | C/O NEUROPACE INC., 455 N. BERNARDO AVENUE, MOUNTAIN VIEW | /s/ Leah Akin, Attorney-in-Fact | 04 Mar 2026 | 0001855616 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NPCE | Common Stock | Sale | $399,250 | -25,000 | -33% | $15.97 | 49,964 | 15 Dec 2025 | Direct | F1, F2 |
| transaction | NPCE | Common Stock | Tax liability | -1,340 | -2.7% | $13.83* | 48,624 | 03 Mar 2026 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.26, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form. |
| F3 | Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |